Pembrolizumab (Keytruda) for primary triple negative breast cancer

Hi all,

I work in the Policy and Campaigns team at Breast Cancer Now.

New breast cancer treatment pembrolizumab (also known as Keytruda) is currently being assessed by the National Institute for Health and Care Excellence (NICE) to see if it can be made available on the NHS for certain patients with primary triple negative breast cancer. It is taken in combination with chemotherapy before surgery and then followed with pembrolizumab alone after surgery. 

Have you received this treatment - perhaps through the clinical trial? If so, we want to hear your experience of the treatment to inform our response to NICE. Your views can be shared anonymously. 

If you want to share your views on this treatment, please get in touch by either emailing or completing a tell us your story form




a out to start and was hoping someone could tell


what side effects to expect